Literature DB >> 22819590

The complexity of adverse side-effects to biological agents.

François Aubin1, Franck Carbonnel, Daniel Wendling.   

Abstract

Whereas adverse effects induced by xenobiotics are mainly linked to the pharmacological effect, the adverse side-effects induced by biological agents (BA) are often target-related and linked to the biological consequences of their action. Based on these differences, an original classification of the adverse effects has been proposed. Five types of adverse effects induced by BA are described (α, β, γ, δ, and ε). This classification provides a very useful scheme for a better understanding of these adverse effects. This approach should help to better characterize the pathogenic mechanisms involved and to optimize their management. Healthcare professionals should be aware of the specific risks related to this relatively new class of drugs. Close monitoring of these BA is therefore recommended.
Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22819590     DOI: 10.1016/j.crohns.2012.06.024

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  8 in total

Review 1.  Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal Antibodies.

Authors:  Chaitali Passey; Satyendra Suryawanshi; Kinjal Sanghavi; Manish Gupta
Journal:  AAPS J       Date:  2018-02-26       Impact factor: 4.009

Review 2.  [Acute hypersensitivity reactions associated with monoclonal antibodies for targeted therapy].

Authors:  B Sachs; H F Merk
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

3.  Disutility Study for Adult Patients with Moderate to Severe Crohn's Disease.

Authors:  Melany Worbes-Cerezo; Beenish Nafees; Andrew Lloyd; Katy Gallop; Imran Ladha; Cicely Kerr
Journal:  J Health Econ Outcomes Res       Date:  2019-03-26

Review 4.  Infliximab-Related Infusion Reactions: Systematic Review.

Authors:  Lev Lichtenstein; Yulia Ron; Shmuel Kivity; Shomron Ben-Horin; Eran Israeli; Gerald M Fraser; Iris Dotan; Yehuda Chowers; Ronit Confino-Cohen; Batia Weiss
Journal:  J Crohns Colitis       Date:  2015-06-19       Impact factor: 9.071

5.  Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models.

Authors:  Claire E J Waterborg; Silke Beermann; Mathijs G A Broeren; Miranda B Bennink; Marije I Koenders; Peter L E M van Lent; Wim B van den Berg; Peter M van der Kraan; Fons A J van de Loo
Journal:  Front Immunol       Date:  2018-04-13       Impact factor: 7.561

6.  Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis.

Authors:  Isabell S von Loga; Aadil El-Turabi; Luke Jostins; Jadwiga Miotla-Zarebska; Jennifer Mackay-Alderson; Andris Zeltins; Ida Parisi; Martin F Bachmann; Tonia L Vincent
Journal:  Ann Rheum Dis       Date:  2019-03-12       Impact factor: 19.103

Review 7.  Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development.

Authors:  Yang Yang; Bing Zhao; Xuejiao Gao; Jinbing Sun; Juan Ye; Jun Li; Peng Cao
Journal:  J Exp Clin Cancer Res       Date:  2021-10-22

8.  Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms.

Authors:  Yi Ru; Xiaojie Ding; Ying Luo; Hongjin Li; Xiaoying Sun; Mi Zhou; Yaqiong Zhou; Le Kuai; Meng Xing; Liu Liu; Yue Luo; Jiankun Song; Jiale Chen; Bin Li; Xin Li
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.